154 related articles for article (PubMed ID: 18823375)
1. TS-1 enhances the effect of radiotherapy by suppressing radiation-induced hypoxia-inducible factor-1 activation and inducing endothelial cell apoptosis.
Zeng L; Ou G; Itasaka S; Harada H; Xie X; Shibuya K; Kizaka-Kondoh S; Morinibu A; Shinomiya K; Hiraoka M
Cancer Sci; 2008 Nov; 99(11):2327-35. PubMed ID: 18823375
[TBL] [Abstract][Full Text] [Related]
2. S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU.
Nakata E; Fukushima M; Takai Y; Nemoto K; Ogawa Y; Nomiya T; Nakamura Y; Milas L; Yamada S
Oncol Rep; 2006 Sep; 16(3):465-71. PubMed ID: 16865244
[TBL] [Abstract][Full Text] [Related]
3. Ononin promotes radiosensitivity in lung cancer by inhibiting HIF-1α/VEGF pathway.
Zhang YM; Miao ZM; Chen YP; Song ZB; Li YY; Liu ZW; Zhou GC; Li J; Shi LL; Chen Y; Zhang SZ; Xu X; He JP; Wang JF; Zhang LY; Liu YQ
Phytomedicine; 2024 Mar; 125():155290. PubMed ID: 38308918
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation.
Nishikawa T; Ramesh R; Munshi A; Chada S; Meyn RE
Mol Ther; 2004 Jun; 9(6):818-28. PubMed ID: 15194048
[TBL] [Abstract][Full Text] [Related]
5. [An advanced pulmonary adenocarcinoma case in which TS-1 proved effective].
Hayashi H; Matsushima Y; Kato H
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1619-21. PubMed ID: 17108714
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of concurrent radiotherapy plus S-1 for treating advanced non-small cell lung cancer.
Zhao D; Feng JF; Wang XH
Medicine (Baltimore); 2018 Jun; 97(22):e10740. PubMed ID: 29851779
[TBL] [Abstract][Full Text] [Related]
7. Combination of S-1 and gefitinib increases the sensitivity to radiotherapy in lung cancer cells.
Cui J; Wang MC; Zhang YM; Ren MZ; Wang SX; Nan KJ; Song LP
Cancer Chemother Pharmacol; 2018 Apr; 81(4):717-726. PubMed ID: 29480364
[TBL] [Abstract][Full Text] [Related]
8. ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity.
Williams KJ; Telfer BA; Brave S; Kendrew J; Whittaker L; Stratford IJ; Wedge SR
Clin Cancer Res; 2004 Dec; 10(24):8587-93. PubMed ID: 15623642
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of HIF-1 imaging for determining optimal timing of combining bevacizumab and radiotherapy.
Ou G; Itasaka S; Zeng L; Shibuya K; Yi J; Harada H; Hiraoka M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):463-7. PubMed ID: 19735869
[TBL] [Abstract][Full Text] [Related]
10. Induction S-1+Concurrent Radiotherapy Followed by Surgical Resection of Locally Advanced Non-small-cell Lung Cancer in an Elderly Patient.
Torigoe H; Toyooka S; Katsui K; Soh J; Maki Y; Kiura K; Miyoshi S
Acta Med Okayama; 2016; 70(1):63-5. PubMed ID: 26899612
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors.
Kadota K; Huang CL; Liu D; Yokomise H; Haba R; Wada H
Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056
[TBL] [Abstract][Full Text] [Related]
12. [Two cases of long-term response treated by S-1 with concurrent radiotherapy followed by S-1 treatment for non-small cell lung cancer patients].
Fujimoto H; Suito T; Oyama T; Kameyama Y; Nakayama S
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1539-41. PubMed ID: 23064067
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of the oral fluoropyrimidine anticancer agent, S-1 and radiation on human oral cancer cells.
Harada K; Kawaguchi S; Supriatno ; Onoue T; Yoshida H; Sato M
Oral Oncol; 2004 Aug; 40(7):713-9. PubMed ID: 15172641
[TBL] [Abstract][Full Text] [Related]
14. S-1-based concurrent chemoradiotherapy in the treatment of locally advanced non-small cell lung cancer: A systematic review and meta-analysis protocol.
Liu F; Wang C; Hu T; Wang W
Medicine (Baltimore); 2018 Apr; 97(15):e0397. PubMed ID: 29642202
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab radiosensitizes non-small cell lung cancer xenografts by inhibiting DNA double-strand break repair in endothelial cells.
Gao H; Xue J; Zhou L; Lan J; He J; Na F; Yang L; Deng L; Lu Y
Cancer Lett; 2015 Aug; 365(1):79-88. PubMed ID: 25982206
[TBL] [Abstract][Full Text] [Related]
16. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.
Ling C; Xie Y; Zhao D; Zhu Y; Xiang J; Yang J
Cancer Gene Ther; 2012 Oct; 19(10):697-706. PubMed ID: 22863759
[TBL] [Abstract][Full Text] [Related]
17. Investigation of optimal schedule of concurrent radiotherapy with S-1 for oral squamous cell carcinoma.
Harada K; Ferdous T; Yoshida H
Oncol Rep; 2007 Nov; 18(5):1077-83. PubMed ID: 17914556
[TBL] [Abstract][Full Text] [Related]
18. Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model.
Kim KW; Moretti L; Mitchell LR; Jung DK; Lu B
Clin Cancer Res; 2009 Oct; 15(19):6096-105. PubMed ID: 19773376
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Notch and HIF enhances the antitumor effect of radiation in Notch expressing lung cancer.
Ikezawa Y; Sakakibara-Konishi J; Mizugaki H; Oizumi S; Nishimura M
Int J Clin Oncol; 2017 Feb; 22(1):59-69. PubMed ID: 27553958
[TBL] [Abstract][Full Text] [Related]
20. S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy in Chinese patients with nonsmall-cell lung cancer: A multicentre randomized controlled trial.
Feng J; Xu J; Wang X; Zhao D
Medicine (Baltimore); 2016 Sep; 95(36):e4557. PubMed ID: 27603346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
